GS0401: Custom manufacture of bacteriophage therapeutics
DM0000: The mark consists of a design made up of hexagons and lines with the words "ADAPTIVE PHAGE" to the right of the design and the word "THERAPEUTICS" underneath "ADAPTIVE PHAGE".
GS0051: Human, animal, plant and microorganism biological preparations for use in drug development, disease modeling and personalized medicine to prevent or treat bacterial infectious diseases; bactericides, namely, biological preparations to treat bacterial infections and bacterial contamination in the fields of medicine, farming, and food preparation; bactericides, namely, biological preparations to treat bacterial contamination in the industrial and food preparation fields; none of the aforementioned goods used in manufacturing
GS0441: Medical testing for diagnostic or treatment purposes in the field of personalized medicine; health care services, namely, providing a database in the field of personalized medicine and featuring inputting and collection of data and information all for treatment and diagnostic purposes; clinical and medical laboratory testing services for diagnostic purposes in the fields of disease diagnostics and personalized medicine
GS0421: Research and development in the fields of personalized medicine and diagnostics; data mining of healthcare and genetic information in the field of precision medicine and personalized medicine; scientific study and research in the fields of biochemistry, disease, personalized medicine, personalized therapeutics, and/or pharmaceuticals; clinical and medical laboratory testing services in the fields of disease diagnostics and personalized medicine; pharmaceutical drug research and development; custom assay development; pharmaceutical drug discovery and development services; providing laboratory research services in the field of medical diagnostics and personalized medicine; medical research services; Biotechnology research; providing medical and scientific research information in the field of clinical trials; research and development of vaccines and therapeutics
Case File Event Statements
3/16/2022 - 2 years ago
12 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDType:MAB2
3/16/2022 - 2 years ago
11 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEType:ABN2
8/27/2021 - 3 years ago
10 - NOTIFICATION OF NON-FINAL ACTION E-MAILEDType:GNRN